期刊
JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH
卷 21, 期 8, 页码 798-805出版社
TAYLOR & FRANCIS LTD
DOI: 10.1080/10286020.2018.1505873
关键词
Non-alcoholic fatty liver disease; curcumin; clinical trial; dyslipidemia
资金
- Gastroenterology and Hepatology Clinic of the Shaheed Baghaee Hospital (Ahvaz, Iran)
- Indena SpA (Milan, Italy)
Curcumin is a safe and dietary phytochemical that can improve different pathophysiologic features of non-alcoholic fatty liver disease (NAFLD). Here, we investigated the efficacy of phospholipidated curcumin supplementation in NAFLD patients. In this single-arm study, 36 patients were recruited. Each patient received three capsules a day (each containing 500 mg of phospholipidated curcumin [overall content of curcuminoids per capsule: 100 mg]) for a period of 8 weeks. The results indicated that phospholipidated curcumin supplementation reduced NAFLD severity and ameliorated ultrasonographic and biochemical measures (including liver transaminases and lipid profile) associated with disease progression. [GRAPHICS] .
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据